Impact of an EHR-based tool on COPD Management in Primary Care by Kelly, Nancy Ann C, RN
Impact of an EHR-based tool on 
COPD management in Primary Care
Primary Investigator: Nancy Kelly, RN DNP Candidate, AGNP
Project Advisor: Dr. Rosemary Dale, Ed.D., ARPN 
Community Contact: Jennifer Allaire, MS, APRN, ANP-C
INTRODUCTION DISCUSSION
Chart 1. Provider Usability Results
ABSTRACT
METHODS 
CONCLUSIONS
REFERENCES
CONTACT
GOLD (2017) guidelines provide 
evidence based recommendations 
for treating COPD, although their 
employment in clinical practice is 
inconsistent.  Lack of a 
standardized method to view 
COPD specific information within 
the EHR during patient 
encounters complicates visits and 
development of GOLD-guided 
treatment plans.  Our goal is to 
determine the impact of an EHR-
based tool on relevant COPD 
disease measurements 
(spirometry rates, pneumococcal 
vaccination rates and COPD 
Action plans) - Adult Primary Care office in Burlington Vermont
- 77 COPD patients identified, age > 18
- 9 participating providers
- Primary Outcome:
Changes in Provider treatment practices
Usability of EHR tool
- Secondary Outcome:
Changes in immunization, spirometry rates, 
Pulmonary Rehab Referrals
- Providers felt EHR tool useful for 
documenting COPD visits; used exclusively 
during COPD acute visits, not Wellness
- Increased recognition of need to perform 
spirometry on more frequent basis
- No changes in COPD Action Plans use
- Patient resistance to Pulmonary Rehab 
despite provider referral
- Influenza vaccinations consistently provided 
to COPD patients in clinic; PNA vaccinations 
given offsite less followthru by patients
- Spirometry data previously scanned into EHR 
less accessible; now directly entered into 
flowsheet
- Spirometry time consuming and may limit 
provider ability to perform during COPD visit
- Educational Intervention
- EHR tool useful to providers in documenting 
COPD encounters. 
- COPD Annual Visits to perform COPD-
specific care (spirometry, action plans, 
Immunization)
- Additional research to evaluate patient 
resistance/barriers to Pulmonary Rehab 
participation
- PNA Vaccination Program Initiative
- COPD 3rd leading cause of death in the US in 
2010 and 3rd leading cause of death 
worldwide by 2020
- Disease exacerbations impact quality of lite 
and increase hospitalizations costing 
$32.1billion in 2010 and $49 billion in 2020
- Preventative measures and disease 
management key to reducing number of 
exacerbations
- Barriers to GOLD guidelines use in Primary 
Care – lack of awareness, time constraints
- Primary Care Providers 1st line to 
diagnose/manage COPD symptoms
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- EHR Tool 
Provider Survey:
- Increase  in need to order Spirometry annually 
and after exacerbation
- Increase in need to create COPD Action Plans 
and update after exacerbation
- No change in ordering Pulmonary Rehab 
referrals – resistance noted by patients
Chart Review:
51/77 Patients seen
109 Office Visits (all cause)
23 COPD visits (CC cough, URI, ED follow up)
Immunizations:
- Influenza: 37.2% (19)
- PCV13:  1.9% (1)
- PPSV23: 1.9% (1)
Spirometry:
- Increase 3.9% (2)
Pulmonary Rehab referrals:
- Increase 3.9% (2)
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